Alzheimer’s drugs ‘make no meaningful difference to patients’, say researchers
- Postato il 16 aprile 2026
- Di Evening Standard
- 0 Visualizzazioni
Alzheimer’s drugs ‘make no meaningful difference to patients’, say researchers
A review, which included licensed drugs lecanemab and donanemab, found the effects were ‘trivial’.